School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.
Global Medical Office, Fresenius Medical Care, 920 Winter Street, Waltham, MA, 02451, USA.
BMC Nephrol. 2020 Dec 7;21(1):529. doi: 10.1186/s12882-020-02187-9.
Dialysis recovery time (DRT) surveys capture the perceived time after HD to return to performing regular activities. Prior studies suggest the majority of HD patients report a DRT > 2 h. However, the profiles of and modifiable dialysis practices associated with changes in DRT relative to the start of dialysis are unknown. We hypothesized hemodialysis (HD) dose and rates of intradialytic hypotension (IDH) would associate with changes in DRT in the first years after initiating dialysis.
We analyzed data from adult HD patients who responded to a DRT survey ≤180 days from first date of dialysis (FDD) during 2014 to 2017. DRT survey was administered with annual KDQOL survey. DRT survey asks: "How long does it take you to be able to return to your normal activities after your dialysis treatment?" Answers are: < 0.5, 0.5-to-1, 1-to-2, 2-to-4, or > 4 h. An adjusted logistic regression model computed odds ratio for a change to a longer DRT (increase above DRT > 2 h) in reference to a change to a shorter DRT (decrease below DRT < 2 h, or from DRT > 4 h). Changes in DRT were calculated from incident (≤180 days FDD) to first prevalent (> 365-to- ≤ 545 days FDD) and second prevalent (> 730-to- ≤ 910 days FDD) years.
Among 98,616 incident HD patients (age 62.6 ± 14.4 years, 57.8% male) who responded to DRT survey, a higher spKt/V in the incident period was associated with 13.5% (OR = 0.865; 95%CI 0.801-to-0.935) lower risk of a change to a longer DRT in the first-prevalent year. A higher number of HD treatments with IDH episodes per month in the incident period was associated with a 0.8% (OR = 1.008; 95%CI 1.001-to-1.015) and 1.6% (OR = 1.016; 95%CI 1.006-to-1.027) higher probability of a change to a longer DRT in the first- and second-prevalent years, respectively. Consistently, an increased in incidence of IDH episodes/months was associated to a change to a longer DRT over time.
Incident patients who had higher spKt/V and less sessions with IDH episodes had a lower likelihood of changing to a longer DRT in first year of HD. Dose optimization strategies with cardiac stability in fluid removal should be tested.
透析恢复时间 (DRT) 调查旨在了解患者在接受血液透析 (HD) 治疗后恢复日常活动的时间。先前的研究表明,大多数 HD 患者报告的 DRT 时间大于 2 小时。然而,相对于开始透析时,与 DRT 变化相关的可改变的透析实践和患者特征尚不清楚。我们假设 HD 剂量和透析中低血压 (IDH) 发生率与开始透析后的 DRT 变化相关。
我们分析了在 2014 年至 2017 年期间,首次接受透析治疗的第 180 天内接受 DRT 调查的成年 HD 患者的数据。DRT 调查与年度 KDQOL 调查一起进行。DRT 调查询问:“您在透析治疗后需要多长时间才能恢复正常活动?”答案为:<0.5、0.5 至 1、1 至 2、2 至 4 或>4 小时。使用调整后的逻辑回归模型计算了相对于 DRT 缩短(DRT <2 小时或 DRT >4 小时)的情况下,DRT 变长(DRT >2 小时)的几率比。DRT 的变化是从首发(≤180 天 FDD)到首次流行(>365 至≤545 天 FDD)和第二次流行(>730 至≤910 天 FDD)年计算得出的。
在 98616 名首发 HD 患者(年龄 62.6±14.4 岁,57.8%为男性)中,首发期的 spKt/V 较高与首发年 DRT 变长的风险降低 13.5%(OR=0.865;95%CI 0.801 至 0.935)相关。首发期每月 IDH 发作的 HD 治疗次数较高与 DRT 变长的几率增加 0.8%(OR=1.008;95%CI 1.001 至 1.015)和 1.6%(OR=1.016;95%CI 1.006 至 1.027)相关。同样,IDH 发作/月的发生率增加与随时间推移 DRT 变长相关。
首发期 spKt/V 较高且 IDH 发作次数较少的患者,在开始 HD 后的第一年更不可能改变 DRT。应该测试以心脏稳定性为目标的液体清除优化策略。